Total lot release volume of MMR vaccinations in China 2015-2020

In 2020, about 42.6 million doses of MMR (measles, mumps, and rubella) vaccine were approved and released in China. Measles, mumps, and rubella are common respiratory infectious diseases among children. Over half of all MMR vaccines released in China are produced by the Shanghai Institute of Biological Products, a subsidiary of the pharmaceutical giant Sinopharm.

于2020年，我国批准并发布了约4260万剂麻腮风（麻疹、风疹和德国麻疹）疫苗。麻疹、风疹和德国麻疹是儿童常见的呼吸道传染病。在我国批准发布的麻腮风疫苗中，超过一半由属于医药巨头中国生物技术股份有限公司的子公司——上海生物制品研究所生产。